Results 181 to 190 of about 8,151 (283)

Mogamulizumab combined with extracorporeal photopheresis for the treatment of refractory mycosis fungoides and Sézary syndrome. Report of seven cases

open access: yesJournal of the European Academy of Dermatology and Venereology, 2023
C. Rubio-Muniz   +6 more
semanticscholar   +1 more source

201: Extracorporeal Photopheresis (ECP) is an Effective Therapy for the Treatment of Children with Steroid Refractory (SR) Chronic Graft vs Host Disease (cGVHD)

open access: hybrid, 2008
K. Thormann   +7 more
openalex   +1 more source

Iron Deficiency Anemia in Patients Undergoing Extracorporeal Photopheresis for Cutaneous T-Cell Lymphoma [PDF]

open access: bronze, 2018
Kimberly Sanford   +3 more
openalex   +1 more source

European dermatology forum: Updated guidelines on the use of extracorporeal photopheresis 2020 – Part 2 [PDF]

open access: bronze, 2020
Robert Knobler   +27 more
openalex   +1 more source

Extracorporeal photopheresis as graft-versus-host disease prophylaxis: a randomized controlled trial: Prophylactic extracorporeal photopheresis to prevent graft-versus-host disease.

open access: yesTransplantation and Cellular Therapy, 2023
M. Ali   +6 more
semanticscholar   +1 more source

Extracorporeal photopheresis reverses experimental graft-versus-host disease through regulatory T cells

open access: green, 2008
Erin Gatza   +7 more
openalex   +1 more source

Home - About - Disclaimer - Privacy